Table 1.
Characteristics of included studies
| Author(s) | Year | Region | Study design | Data source | Multicentre | Time of enrolment | Patients with STEMI (n) | Female | Endpoint | Follow-up |
| Venetsanos et al10 | 2017 | 13 countries | Prospective | Clinical registry | Yes | September 2011–October 2013 | 1862 | 369 (20.0) | Major adverse cardiovascular events and definite stent thrombosis | 30 days |
| Ali et al11 | 2018 | Germany | Prospective | Administrative database | No | 2013–2017 | 312 | 101 (32.4) | All-cause in-hospital mortality | NA |
| Langabeer et al12 | 2018 | USA | Prospective | Clinical registry | Yes | January 2010-December 2015 | 9674 | 2569 (26.6) | In-hospital mortality | NA |
| Tang et al13 | 2018 | China | Prospective | Administrative database | No | January 2013–December 2013 | 1238 | 210 (1.9) | Major adverse cardiac and cerebrovascular events | 730±30 days |
| Cenko et al14 | 2019 | 12 European countries | Prospective | Clinical registry | Yes | January 2010–July 2018 | 10 443 | 3112 (29.8) | 30-day all-cause mortality | 30 days |
| Hao et al15 | 2019 | China | Prospective | Clinical registry | Yes | November 2014–June 2018 | 50 203 | 11 016 (21,9) | In-hospital mortality | NA |
| Hannan et al16 | 2019 | USA | Retrospective | Administrative database | Yes | January 2013–December 2015 | 23 809 | 7791 (32.7) | In-hospital/30-day mortality | 30 days |
| Maznyczka et al17 | 2019 | UK | Retrospective | Clinical registry | No | July 2011–November 2012 | 324 | 87 (26.9) | All-cause death/first heart failure hospitalisation | 5 years |
| Stehli et al18 | 2019 | Australia | Prospective | Clinical registry | Yes | 2013–2016 | 6431 | 1317 (20.5) | In-hospital/30-day major adverse events, and major bleeding | 30 days |
| Burgess et al19 | 2020 | Australia | Prospective | Administrative database | No | December 2010–April 2014 | 589 | 123 (21) | Cardiac death and myocardial infarction | 2 years |
| Dharma et al20 | 2020 | Indonesia | Retrospective | Administrative database | No | February 2011-August 2019 | 6557 | 929 (14.2) | All-cause mortality | 30 days and 1 year |
| Kerkman et al21 | 2020 | Netherlands | Retrospective | Administrative database | Yes | 2015–2016 | 787 | 229 (29) | All-cause mortality | 1 year |
| Siabani et al22 | 2020 | Iran | Prospective | Clinical registry | No | June 2016–May 2018 | 1484 | 311(21) | In-hospital mortality | NA |
| Tai et al23 | 2020 | China | Retrospective | Administrative database | No | January 2013–December 2017 | 182 | 56 (30.8) | In-hospital/1-year mortality | 1 year |
| Tizón-Marcos et al24 | 2020 | Spain | Prospective | Clinical registry | Yes | 2010–2016 | 14 690 | 3486 (23.7) | 30-day/1-year all-cause mortality | 1 year |
STEMI, ST-segment elevation myocardial infarction.